Frederick E. Munschauer has been appointed vice president of Medical Affairs, Neurology and Immunology at EMD Serono, the U.S. biopharmaceuticals subsidiary of Merck KGaA, Darmstadt, Germany. Dr. Munschauer will lead the medical affairs activities for clinical, commercial and business development projects and collaborations for Rebif (interferon beta-1a) as well as the company’s Immunology and Neurology pipeline.
 
Dr. Munschauer has more than 30 years of experience in neurology, specifically multiple sclerosis. He joins the company from Biogen, where he most recently as chief medical advisor. During his tenure at Biogen he also served as head, US Medical Affairs and head, Global Medical Affairs.
 
“Dr. Munschauer brings an exceptional level of expertise to our medical affairs team and we are confident that with his leadership will be able to deliver even stronger outcomes for patients,” said Dr. Thorsten Eickenhorst, chief medical officer, EMD Serono. “His contributions to the MS community since he began his career in neurology, combined with his deep understanding of the needs for physicians and payers in clinical medicine will bring added value to our ongoing neurology and immunology research and development efforts.”